Navigation Links
Synergy Research Group Releases Q2, 2014 Orange Paper
Date:8/6/2014

Moscow, Russia (PRWEB) August 06, 2014

Synergy Research Group has released its Q2, 2014 Orange Paper. Published since 2006, the Synergy Orange Paper gives an unbiased and detailed view of the state of clinical trials in Russia. The report, which is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies and their country of origin.

The Synergy Orange Paper is relied on by the local and international life science and business community involved in clinical trials. The report compares current data with previous numbers so readers can see year-over-year changes.

“We started publishing the Orange Paper because clinical research in Russia is a dynamic marketplace that is increasingly attractive globally,” said Igor Stefanov, CEO of Synergy Research Group. “Having detailed information on the state of clinical research in the region allows sponsors to make better informed decisions."

Russia has large patient populations across high-demand therapeutic areas such as oncology, central nervous system, and cardiovascular. Additionally, the per-patient spend on pharmaceuticals is expected to more than double by 2016, growing to more than four billion dollars annually.

“Since we started publishing the Synergy Orange Paper, we have had a lot of feedback from all over the world telling us how much people rely on it,” Stefanov continued. “We feel it is well worth the investment we put into creating it.”

Synergy Research Group leads the Russian market in full-service contract research. The company has senior management teams with deep domain expertise, as well as executives with experience working inside regulatory agencies who speed the approval processes.

About Synergy Research Group
Synergy Research Group, http://www.synrg-pharm.com, is a full-service Contract Research Organization (CRO) founded in 2002 that delivers its Troika Promise of Speed, Cost and Quality to clients. Synergy provides a full range of CRO services to help global pharmaceutical and biotechnology companies conduct successful and cost-effective clinical trials. The company provides transparency, access and control to sponsors during the entire project through its cloud-based monitoring system. Synergy has locations in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm, Krasnodar, Almaty and Astana (Kazakhstan) and Kyiv (Ukraine). The company's headquarters are in Moscow.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076661.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. SYNERGY HomeCare Offers Free Home Safety Assessments
2. Moffitt researcher investigates 2-drug synergy to treat drug-resistant chronic myeloid leukemia
3. Phoenix Synergy Discusses securing computer networks at the AZPMA conference in Las Vegas
4. Synergy Wellness & Weight Releases Article on Healthcare Prevention
5. Announcement: NutriSynergy, LLC is Offering a Webinar Presentation with Jason Bartels
6. Voltari Corporation Selects Intacct Cloud Financials and Synergy Business Solutions for New Accounting System and Implementation
7. Searching for therapeutic synergy in primary effusion lymphoma
8. Synergy Lifestyle Center Brings New Age Management Program to Bakersfield, CA
9. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
10. SYNERGY HomeCare Wins Two Prestigious Endorsements
11. NuScale Power Selects Synergy Business Solutions to Implement Microsoft Dynamics SL Project-accounting and Financial Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
Breaking Medicine Technology: